TMCnet News
Global Chiral Technology IndustryNEW YORK, Feb. 23, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Chiral Technology in US$ Thousand by the following Products: Intermediates, Analytical, and Others. The End Use markets also analyzed in the report include Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as - 9. CHIRAL ISOMERISM.............. II-54 Organic Chemical Isomerism Types II-54 Structural Isomerism..............II-54 Chain Isomerism.............. II-54 Position Isomerism..............II-54 Functional Group Isomerism..............II-54 Stereoisomerism.............. II-54 Dynamic Isomerism (Tautomerism) II-55 Patents.............. II-55 10. REGULATORY & ENVIRONMENTAL ISSUES - A REVIEW II-56 11. PRODUCT INTRODUCTIONS/INNOVATIONS II-57 Phenomenex Unveils Lux i-Cellulose-5 Chiral Columns II-57 Chiral Technologies Launches CHIRALPAK® IG II-57 Phenomenex Introduces Amylose-1 Chiral Stationary Phase II-57 Regis Technologies Extends Chiral Column Product Line II-57 Chiral Technologies Unveils CHIRALFLASH MPLC Columns II-57 Phenomenex Extends Lux Chiral Bulk Media Line with Lux Cellulose-3 and Cellulose-4..............II-58 Chiral Technologies Introduces i-CHIRAL 4 II-58 12. RECENT INDUSTRY ACTIVITY..............II-59 Chiral Technologies and GreenCentre Canada Inks Agreement II-59 Chiral Technologies Partners with Strem Chemicals II-59 Jingbo Agrochemical Opens High Chiral Ratio Indoxacarb Technical Manufacturing Plant II-59 Johnson Matthey Takes Over Pharmorphix II-59 Merck Snaps Up Sigma-Aldrich..............II-59 Nagase America Partners with Aspira Scientific II-59 SAFC Partners with BioTools..............II-60 Chiral Technologies Inks Agreement with Sagu Chile II-60 Johnson Matthey Catalysis and Chiral Technologies Expand Ligand Manufacturing Capability II-60 13. FOCUS ON SELECT PLAYERS..............II-61 Agilent Technologies, Inc. (USA) II-61 Albemarle Corporation (USA)..............II-61 BASF SE (Germany).............. II-62 Cambrex Corporation (USA)..............II-62 Chiral Quest (Suzhou) Co., Ltd. (China) II-62 Chiral Technologies, Inc. (USA)..............II-63 Daicel Corporation (Japan)..............II-63 Johnson Matthey PLC (UK)..............II-64 Phenomenex, Inc. (USA)..............II-64 Regis Technologies, Inc. (USA) II-64 Shasun Pharmaceuticals Limited (India) II-65 Shimadzu Corporation (Japan)..............II-65 Sigma Aldrich Corp. (USA)..............II-66 Solvias AG (Switzerland)..............II-66 Thermo Fisher Scientific, Inc. (USA) II-67 YMC America, Inc. (USA)..............II-67 14. GLOBAL MARKET PERSPECTIVE..............II-68 Table 3: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-68 Table 4: World Historic Review for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-69 Table 5: World 14-Year Perspective for Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. II-70 Table 6: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-71 Table 7: World Historic Review for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-72 Table 8: World 14-Year Perspective for Chiral Intermediates by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-73 Table 9: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-74 Table 10: World Historic Review for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-75 Table 11: World 14-Year Perspective for Chiral Analytical Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-76 Table 12: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-77 Table 13: World Historic Review for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) II-78 Table 14: World 14-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............II-79 Table 15: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-80 Table 16: World Historic Review for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-81 Table 17: World 14-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. II-82 Table 18: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-83 Table 19: World Historic Review for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-84 Table 20: World 14-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. II-85 III. MARKET 1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Overview.............. III-1 Product Launches..............III-1 Strategic Corporate Developments III-3 Select Key Players..............III-3 B.Market Analytics..............III-8 Table 21: The US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-8 Table 22: The US Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-9 Table 23: The US 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-10 Table 24: The US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-11 Table 25: The US Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-12 Table 26: The US 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-13 2. JAPAN.............. III-14 A.Market Analysis.............. III-14 Select Key Players..............III-14 B.Market Analytics..............III-16 Table 27: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-16 Table 28: Japanese Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-17 Table 29: Japanese 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-18 Table 30: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-19 Table 31: Japanese Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-20 Table 32: Japanese 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-21 3. EUROPE.............. III-22 A.Market Analysis.............. III-22 Overview.............. III-22 Strategic Corporate Developments III-22 Select Key Players..............III-23 B.Market Analytics..............III-24 Table 33: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-24 Table 34: European Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-25 Table 35: European 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-26 Table 36: European Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-27 Table 37: European Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-28 Table 38: European 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-29 4. REST OF WORLD.............. III-30 A.Market Analysis.............. III-30 China-A Hub for Pharmaceutical Manufacturing III-30 Strategic Corporate Developments III-30 Select Key Players..............III-31 B.Market Analytics..............III-32 Table 39: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-32 Table 40: Rest of World Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-33 Table 41: Rest of World 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-34 Table 42: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-35 Table 43: Rest of World Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-36 Table 44: Rest of World 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-37 IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 31 (including Divisions/Subsidiaries - 34) The United States (18) Japan (3) Europe (8) - France (1) - Germany (2) - The United Kingdom (2) - Rest of Europe (3) Asia-Pacific (Excluding Japan) (5) Read the full report: http://www.reportlinker.com/p04368306-summary/view-report.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-chiral-technology-industry-300413087.html SOURCE Reportlinker |